AU2544300A - Immunogenic compounds - Google Patents

Immunogenic compounds

Info

Publication number
AU2544300A
AU2544300A AU25443/00A AU2544300A AU2544300A AU 2544300 A AU2544300 A AU 2544300A AU 25443/00 A AU25443/00 A AU 25443/00A AU 2544300 A AU2544300 A AU 2544300A AU 2544300 A AU2544300 A AU 2544300A
Authority
AU
Australia
Prior art keywords
immunogenic compounds
immunogenic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25443/00A
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU2544300A publication Critical patent/AU2544300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU25443/00A 1999-01-29 2000-01-25 Immunogenic compounds Abandoned AU2544300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9902084.4A GB9902084D0 (en) 1999-01-29 1999-01-29 Novel compounds
GB9902084 1999-01-29
PCT/EP2000/000560 WO2000044890A1 (en) 1999-01-29 2000-01-25 Immunogenic compounds

Publications (1)

Publication Number Publication Date
AU2544300A true AU2544300A (en) 2000-08-18

Family

ID=10846802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25443/00A Abandoned AU2544300A (en) 1999-01-29 2000-01-25 Immunogenic compounds

Country Status (5)

Country Link
EP (1) EP1153126A1 (en)
AU (1) AU2544300A (en)
CA (1) CA2360084A1 (en)
GB (1) GB9902084D0 (en)
WO (1) WO2000044890A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9910089A (en) * 1998-05-01 2004-06-08 Chiron Corp Compositions and antigens of neisseria meningitidis
EP2275552B1 (en) 1999-10-29 2015-09-09 GlaxoSmithKline Biologicals SA Neisserial antigenic peptides
PT2270030E (en) 2000-02-28 2012-07-24 Novartis Vaccines & Diagnostic Heterologous expression of neisserial proteins
MX339524B (en) 2001-10-11 2016-05-30 Wyeth Corp Novel immunogenic compositions for the prevention and treatment of meningococcal disease.
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
EP1612218B1 (en) * 2004-06-29 2008-05-14 Center for Disease Control Department of Health Taiwan Surface protein of Neisseria bacteria
AR064642A1 (en) 2006-12-22 2009-04-15 Wyeth Corp POLINUCLEOTIDE VECTOR THAT INCLUDES IT RECOMBINATING CELL THAT UNDERSTANDS THE VECTOR POLYPEPTIDE, ANTIBODY, COMPOSITION THAT UNDERSTANDS THE POLINUCLEOTIDE, VECTOR, RECOMBINATING CELL POLYPEPTIDE OR ANTIBODY, USE OF THE COMPOSITION AND A COMPOSITION AND A METHOD
ES2850973T3 (en) 2010-08-23 2021-09-01 Wyeth Llc Stable formulations of rLP2086 antigens from Neisseria meningitidis
WO2012032489A1 (en) 2010-09-10 2012-03-15 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
EP3299467B1 (en) 2012-02-02 2021-08-11 GlaxoSmithKline Biologicals SA Promoters for increased protein expression in meningococcus
NZ628449A (en) 2012-03-09 2016-04-29 Pfizer Neisseria meningitidis compositions and methods thereof
SA115360586B1 (en) 2012-03-09 2017-04-12 فايزر انك Neisseria meningitidis compositions and methods thereof
JP6446377B2 (en) 2013-03-08 2018-12-26 ファイザー・インク Immunogenic fusion polypeptide
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
BR112017017460A2 (en) 2015-02-19 2018-04-10 Pfizer Inc. neisseria meningitidis compositions and methods thereof
CN110234658B (en) 2017-01-31 2024-03-12 辉瑞大药厂 Neisseria meningitidis compositions and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739624B1 (en) * 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc NEW NEISSERIA MENINGITIDIS TBP2 SUBUNIT
US6472518B1 (en) * 1996-10-24 2002-10-29 Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services Invasion associated genes from Neisseria meningitidis serogroup B
US6403306B1 (en) * 1997-04-09 2002-06-11 Emory University Serogroup-specific nucleotide sequences in the molecular typing of bacterial isolates and the preparation of vaccines thereto
BR9910089A (en) * 1998-05-01 2004-06-08 Chiron Corp Compositions and antigens of neisseria meningitidis

Also Published As

Publication number Publication date
EP1153126A1 (en) 2001-11-14
CA2360084A1 (en) 2000-08-03
WO2000044890A1 (en) 2000-08-03
GB9902084D0 (en) 1999-03-24

Similar Documents

Publication Publication Date Title
AU5413600A (en) Compounds
AU1278701A (en) Novel compounds
AU1173201A (en) Skin-gripper
AU2408300A (en) Novel compounds
AU2544300A (en) Immunogenic compounds
AU1746401A (en) Compounds
AU6032100A (en) New compounds
AU3997700A (en) Anti-first-pass effect compounds
AU5977700A (en) Vaccines
AU6158700A (en) Vaccine
AU4132200A (en) Novel compounds
AU2109700A (en) Novel compounds
AU2913600A (en) Immunogenic compounds
AU5787901A (en) Compound
AU1901801A (en) Glucofuranoses
AU5811600A (en) Vaccine
AU1915601A (en) Periotome
AU5119400A (en) Compounds
AU2288900A (en) Novel compounds
AU6168900A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU1385701A (en) Novel compounds
AU7784700A (en) Novel compounds
AU4156800A (en) Novel compounds
AU5084300A (en) New vaccine formulations - 1

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase